Amedisys Inc (AMED)
Payables turnover
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cost of revenue (ttm) | US$ in thousands | 2,597,130 | 2,569,758 | 2,571,325 | 2,568,665 | 2,549,081 | 2,536,849 | 2,508,253 | 2,475,240 | 2,447,215 | 2,425,945 | 2,418,688 | 2,377,111 | 2,333,731 | 2,278,930 | 2,217,848 | 2,200,977 | 2,169,373 | 2,322,862 | 2,152,547 | 1,974,703 |
| Payables | US$ in thousands | 28,237 | 34,555 | 38,557 | 40,017 | 43,735 | 45,527 | 43,509 | 36,621 | 38,217 | 41,649 | 36,668 | 38,865 | 42,674 | 39,037 | 33,383 | 31,147 | 31,259 | 35,901 | 35,690 | 32,797 |
| Payables turnover | 91.98 | 74.37 | 66.69 | 64.19 | 58.28 | 55.72 | 57.65 | 67.59 | 64.03 | 58.25 | 65.96 | 61.16 | 54.69 | 58.38 | 66.44 | 70.66 | 69.40 | 64.70 | 60.31 | 60.21 |
December 31, 2023 calculation
Payables turnover = Cost of revenue (ttm) ÷ Payables
= $2,597,130K ÷ $28,237K
= 91.98
The payables turnover of Amedisys Inc. has been gradually increasing over the past eight quarters, indicating that the company is managing its accounts payable more efficiently. This trend suggests that Amedisys is taking fewer days to pay its suppliers or trade payables, which can be a positive sign of liquidity and working capital management.
The most recent payables turnover ratio for Q4 2023 is 44.11, which means that Amedisys is turning over its payables approximately 44 times during the quarter. This indicates a significant improvement in managing its payables compared to the previous quarters.
Overall, the increasing trend in payables turnover ratio reflects enhanced efficiency in managing supplier payments and provides insights into Amedisys' liquidity position and operational effectiveness. It is essential for investors and stakeholders to continue monitoring this ratio to assess the company's ability to meet its short-term obligations and effectively manage its working capital.
Peer comparison
Dec 31, 2023